首页> 外文OA文献 >Multistep continuous-flow synthesis in medicinal chemistry:discovery and preliminary structure-activity relationships of CCR8 ligands
【2h】

Multistep continuous-flow synthesis in medicinal chemistry:discovery and preliminary structure-activity relationships of CCR8 ligands

机译:药物化学中的多步连续流合成:CCR8配体的发现与初步构效关系

摘要

A three-step continuous-flow synthesis system and its application to the assembly of a new series of chemokine receptor ligands directly from commercial building blocks is reported. No scavenger columns or solvent switches are necessary to recover the desired test compounds, which were obtained in overall yields of 49-94%. The system is modular and flexible, and the individual steps of the sequence can be interchanged with similar outcome, extending the scope of the chemistry. Biological evaluation confirmed activity on the chemokine CCR8 receptor and provided initial structure-activity-relationship (SAR) information for this new ligand series, with the most potent member displaying full agonist activity with single-digit nanomolar potency. To the best of our knowledge, this represents the first published example of efficient use of multistep flow synthesis combined with biological testing and SAR studies in medicinal chemistry.
机译:报道了一种三步连续流合成系统及其在直接从商业构件中组装新系列趋化因子受体配体中的应用。无需任何清除剂塔或溶剂开关即可回收所需的测试化合物,这些化合物的总收率为49-94%。该系统是模块化且灵活的,该序列的各个步骤可以互换获得相似的结果,从而扩展了化学反应的范围。生物学评估证实了对趋化因子CCR8受体的活性,并为该新的配体系列提供了初始结构-活性-关系(SAR)信息,其中最有效的成员显示了全激动剂活性,单位为纳摩尔浓度。据我们所知,这是在药物化学中有效利用多步流合成与生物测试和SAR研究相结合的第一个公开实例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号